Healwell AI Inc. (TSE:AID – Free Report) – Maxim Group lowered their FY2026 earnings estimates for Healwell AI in a research note issued on Tuesday, November 10th. Maxim Group analyst A. Klee now anticipates that the company will post earnings per share of ($0.08) for the year, down from their prior forecast of ($0.04). Maxim Group has a “Strong-Buy” rating on the stock. Maxim Group also issued estimates for Healwell AI’s Q4 2026 earnings at ($0.03) EPS, Q2 2027 earnings at ($0.02) EPS, Q3 2027 earnings at ($0.02) EPS, Q4 2027 earnings at ($0.02) EPS and FY2027 earnings at ($0.09) EPS.
Separately, Canaccord Genuity Group raised Healwell AI to a “moderate buy” rating in a report on Tuesday, July 28th. Two equities research analysts have rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Strong Buy”.
View Our Latest Research Report on AID
Healwell AI Price Performance
Featured Stories
- Five stocks we like better than Healwell AI
- Palantir’s Real Washington Risk Isn’t the Budget—It’s Oversight
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
Receive News & Ratings for Healwell AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healwell AI and related companies with MarketBeat.com's FREE daily email newsletter.
